- Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
- Nautilus Biotechnology Reports First Quarter 2024 Financial Results
- Nautilus Biotechnology to Announce First Quarter 2024 Financial Results on April 30, 2024
- Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2023 Financial Results
- Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference
- Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
- Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with US HUPO Computational Proteomics Award
- Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development
- Nautilus Biotechnology Reports Third Quarter 2023 Financial Results
- Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
More ▼
Key statistics
On Wednesday, Nautilus Biotechnology Inc (NAUT:NSQ) closed at 2.27, 3.65% above its 52-week low of 2.19, set on Jun 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.29 |
---|---|
High | 2.33 |
Low | 2.26 |
Bid | 2.22 |
Offer | 2.37 |
Previous close | 2.27 |
Average volume | 105.88k |
---|---|
Shares outstanding | 125.27m |
Free float | 70.45m |
P/E (TTM) | -- |
Market cap | 284.35m USD |
EPS (TTM) | -0.5402 USD |
Data delayed at least 15 minutes, as of Jul 03 2024 18:00 BST.
More ▼